Related Experiment Videos
Heparin binding and protease inhibitor activity of chemically modified antithrombin III
Annals of the New York Academy of Sciences
|January 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.
Clinical and experimental immunology·2002
New insights into the size and stoichiometry of the plasminogen activator inhibitor type-1.vitronectin complex.
The Journal of biological chemistry·2000
An inhibitory anti-factor IX antibody effectively reduces thrombus formation in a rat model of venous thrombosis.
Thrombosis and haemostasis·1999
Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats.
Arteriosclerosis, thrombosis, and vascular biology·1999
Dual-Component Surface-Enhanced Raman Scattering Detection of Tetracycline Based on Aptamer-Regulated Catalytic Switch.
Annals of the New York Academy of Sciences·2026
Deep Learning-Based Intelligent Resource Management for Renewable Energy Engineering Projects.
Annals of the New York Academy of Sciences·2026
Rhythm Across Species: Situating Human Speech in a Comparative Framework.
Annals of the New York Academy of Sciences·2026
Engineering Antivenom: Research Progress and Future Directions in Snakebite Envenoming Therapy.
Annals of the New York Academy of Sciences·2026
Loneliness Biases Social Engagement Decisions: Evidence From Value-Based Choice Models.
Annals of the New York Academy of Sciences·2026
Urban Climate Risk Governance and Corporate Energy Intensity: Evidence From China's Climate Adaptation City Pilots.
Annals of the New York Academy of Sciences·2026